FRAZIER MANAGEMENT LLC - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 89 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
FRAZIER MANAGEMENT LLC ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q4 2021$24,721,000
+30.8%
1,784,913
+0.7%
1.90%
+25.8%
Q3 2021$18,906,000
-18.3%
1,771,844
-31.1%
1.51%
-29.1%
Q2 2021$23,143,000
-15.1%
2,571,4500.0%2.13%
-2.4%
Q1 2021$27,257,000
-15.9%
2,571,4500.0%2.19%
-12.4%
Q4 2020$32,400,000
+43.3%
2,571,4500.0%2.50%
+23.0%
Q3 2020$22,603,000
-9.5%
2,571,4500.0%2.03%
-7.5%
Q2 2020$24,969,000
+237.1%
2,571,4500.0%2.19%
+161.1%
Q1 2020$7,406,000
-25.0%
2,571,4500.0%0.84%
-49.3%
Q4 2019$9,874,000
-3.0%
2,571,4500.0%1.66%
-48.0%
Q3 2019$10,183,000
-5.9%
2,571,4500.0%3.18%
+14.8%
Q2 2019$10,826,000
-38.6%
2,571,4500.0%2.77%
-34.7%
Q1 2019$17,640,000
+118.0%
2,571,450
+16.9%
4.25%
+103.4%
Q4 2018$8,092,000
-41.9%
2,199,0110.0%2.09%
-18.1%
Q3 2018$13,920,000
-16.4%
2,199,0110.0%2.55%
-26.1%
Q2 2018$16,647,000
-5.4%
2,199,0110.0%3.45%
+18.1%
Q1 2018$17,592,000
-28.6%
2,199,0110.0%2.92%
-26.9%
Q4 2017$24,629,000
-3.4%
2,199,0110.0%3.99%
-56.1%
Q3 2017$25,509,0002,199,0119.10%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$23,143,0002.13%
Omega Fund Management, LLC 1,284,900$11,564,0001.31%
Avidity Partners Management LP 1,495,000$13,455,0000.36%
Samsara BioCapital, LLC 275,169$2,477,0000.31%
Orbimed Advisors 3,070,955$27,639,0000.28%
Ikarian Capital, LLC 300,454$2,704,0000.22%
TIGER MANAGEMENT L.L.C. 137,728$1,240,0000.22%
DAFNA Capital Management LLC 113,302$1,020,0000.21%
EcoR1 Capital, LLC 522,635$4,704,0000.18%
Artal Group S.A. 593,030$5,337,0000.11%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders